BIOTECHNOLOGY VALUE FUND L P

SAN FRANCISCO, CA Hedge Fund How do I update this listing?

Biotechnology Value Fund L P is based out of San Francisco. Whalewisdom has at least 88 13D filings, 462 13G filings, and 1 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2019-01-11. The filing was for a pooled investment fund: hedge fund The notice included securities offered of Pooled Investment Fund Interests

Create Email Alert

Contact Info

biotechnology value fund l p
44 MONTGOMERY STREET
SAN FRANCISCO CA    94104

Business Phone: 3125066500
SEC SIC CODE:
6282-INVESTMENT ADVICE
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
ArQule, Inc. (ARQL) HEALTH CARE 8,670,350 95,460,553.50 1 13G 2018-12-31
Unknown (unknown) 1,750,000 86,642,500.00 2 13G 2017-04-13
Merus BV (MRUS) HEALTH CARE 4,514,913 66,143,475.45 3 13G 2018-12-31
Cytokinetics Inc (CYTK) HEALTH CARE 5,515,256 62,046,630.00 4 13G 2019-01-08
Realm Therapeutics PLC (RLM) HEALTH CARE 21,451,171 60,277,790.51 5 13G 2018-12-31
Cascadian Therapeutics, Inc. (CASC) HEALTH CARE 6,008,224 60,202,404.48 6 13G 2017-02-02
AC Immune SA (ACIU) HEALTH CARE 11,297,911 59,314,032.75 7 13G 2019-09-12
Kura Oncology Inc (KURA) HEALTH CARE 2,775,156 54,642,821.64 8 13G 2018-12-31
ChemoCentryx, Inc. (CCXI) HEALTH CARE 4,105,215 38,178,499.50 9 13G 2019-02-12
Pieris Pharmaceuticals Inc (PIRS) HEALTH CARE 7,457,921 35,052,228.70 10 13G 2018-12-31
Erytech Pharma SA ADR (ERYP) HEALTH CARE 4,547,662 32,502,140.31 11 13D 2018-11-06
Infinity Pharmaceuticals Inc (INFI) HEALTH CARE 17,151,968 30,873,542.40 12 13D 2018-11-19
Protagonist Therapeutics Inc (PTGX) HEALTH CARE 2,502,390 30,303,942.90 13 13G 2018-12-31
Molecular Templates Inc (MTEM) HEALTH CARE 3,364,421 28,092,915.35 14 13G 2018-12-31
Calithera Biosciences Inc (CALA) HEALTH CARE 6,750,482 26,326,879.80 15 13G 2019-06-19
Xoma Corporation (XOMA) HEALTH CARE 1,769,029 26,287,770.94 16 13D 2018-12-18
Xenon Pharmaceuticals Inc (XENE) HEALTH CARE 2,602,836 25,663,962.96 17 13G 2018-12-31
GlycoMimetics Inc (GLYC) HEALTH CARE 7,361,801 24,441,179.32 18 13G 2019-09-05
Syndax Pharmaceuticals Inc (SNDX) HEALTH CARE 2,535,878 23,609,024.18 19 13G 2018-12-31
Replimune Group Inc (REPL) HEALTH CARE 1,606,817 23,555,937.22 20 13G 2019-03-15
Spero Therapeutics Inc (SPRO) HEALTH CARE 1,815,146 20,892,330.46 21 13G 2018-12-31
Arcus Biosciences Inc (RCUS) HEALTH CARE 2,411,623 19,172,402.85 22 13G 2018-12-31
Forward Pharma A/S ADR (FWP) HEALTH CARE 18,092,758 17,061,470.79 23 13G 2018-12-31
Concert Pharmaceuticals Inc (CNCE) HEALTH CARE 1,408,187 16,799,670.91 24 13G 2019-07-02
Five Prime Therapeutics Inc (FPRX) HEALTH CARE 2,781,346 16,771,516.38 25 13G 2018-12-31
IDEAYA Biosciences Inc (IDYA) 1,505,429 14,994,072.84 26 13G 2019-05-28
Galmed Pharmaceuticals Ltd (GLMD) HEALTH CARE 1,878,508 13,807,033.80 27 13G 2018-12-31
BioLineRX Ltd ADR (BLRX) HEALTH CARE 2,130,563 11,824,619.48 28 13D 2019-02-07
MEI Pharma Inc (MEIP) HEALTH CARE 4,518,861 11,297,152.50 29 13G 2018-12-31
Cti Biopharma Co (CTIC) HEALTH CARE 12,753,896 10,968,350.56 30 13D 2018-02-08
Corvus Pharmaceuticals Inc (CRVS) HEALTH CARE 3,032,850 10,433,004.00 31 13G 2019-08-05
Mersana Therapeutics Inc (MRSN) HEALTH CARE 2,500,000 10,125,000.00 32 13G 2019-03-01
Regado BioSciences, Inc. (TBRA) HEALTH CARE 209,148 8,803,923.21 33 13G 2014-12-31
Verastem Inc (VSTM) HEALTH CARE 5,512,994 8,324,620.94 34 13G 2019-05-10
Ovid Therapeutics Inc (OVID) HEALTH CARE 3,772,000 6,978,200.00 35 13G 2019-02-20
VBI VACCINES INC COM (VBIV) FINANCE 5,216,857 6,103,722.69 36 13G 2018-12-13
Alpine Immune Sciences Inc (ALPN) HEALTH CARE 1,201,718 5,059,232.78 37 13G 2019-01-18
Cidara Therapeutics Inc (CDTX) HEALTH CARE 2,904,684 4,879,869.12 38 13G 2018-12-21
Merrimack Pharmaceuticals Inc (MACK) HEALTH CARE 917,579 4,367,706.34 39 13G 2018-12-31
Genocea Biosciences Inc (GNCA) HEALTH CARE 951,807 3,731,082.97 40 13G 2018-12-31
Spring Bank Pharmaceuticals Inc (SBPH) HEALTH CARE 951,701 3,511,776.69 41 13G 2018-12-31
Essa Pharma Inc (EPIX) HEALTH CARE 1,329,700 3,257,765.00 42 13G 2019-06-24
Sunesis Pharmaceuticals Inc (SNSS) HEALTH CARE 3,895,026 2,843,368.98 43 13G 2018-12-31
Vical Inc. (VICL) HEALTH CARE 325,678 1,937,781.95 44 13G 2019-04-08
Novus Therapeutics Inc (NVUS) HEALTH CARE 1,336,556 1,349,921.56 45 13G 2019-04-30
Regulus Therapeutics Inc (RGLS) HEALTH CARE 1,051,940 1,314,925.00 46 13G 2018-12-31
GlobeImmune Inc (GBIM) HEALTH CARE 657,653 157,836.72 47 13G 2015-12-31
Aeolus Pharmaceutical (AOLS) HEALTH CARE 15,213,480 152,134.80 48 13G 2015-12-31
Anthera Pharmaceuticals Inc (ANTH) HEALTH CARE 1,658,157 116,070.99 49 13G 2017-12-31
Orexigen Therapeutics Inc (OREXQ) HEALTH CARE 2,036,860 20,368.60 50 13G 2018-12-31
X4 PHARMACEUTICALS ORD SHS (XFOR) 1,292,416 51 13G 2019-04-16

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-01-11 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2017-12-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2016-09-21 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 212,032,682 INDEFINITE
2014-11-12 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 64,755,500 INDEFINITE
2013-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 41,655,500 INDEFINITE
2012-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 37,655,500 INDEFINITE
2011-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 36,155,500 INDEFINITE
2010-10-21 D POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 34,905,500 INDEFINITE
2009-10-15 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 29,155,500 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
JAMES KRATKY subscription required
    EXECUTIVE OFFICER
MARC N. LAMPERT subscription required
    EXECUTIVE OFFICER
MARK N LAMPERT subscription required
    EXECUTIVE OFFICER
MATTHEW D PERRY subscription required
    EXECUTIVE OFFICER
MITCHELL KAYE subscription required
    EXECUTIVE OFFICER
N/A BVF INC. subscription required
    EXECUTIVE OFFICER
N/A BVF PARTNERS, L.P. subscription required
    EXECUTIVE OFFICER
OLEG NODELMAN subscription required
    EXECUTIVE OFFICER
SPIKE LOY subscription required
    EXECUTIVE OFFICER

Elevate your investments